Skip to main content

Find Clinical Trials

Home
Conditions
Stage III Adult T-cell Leukemia/Lymphoma

Clinical trial condition

Stage III Adult T-cell Leukemia/Lymphoma

Explore clinical trials studying Stage III Adult T-cell Leukemia/Lymphoma. Study availability and eligibility vary by location and protocol.

18 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Adult T-cell Leukemia/Lymphoma trial results

Completed

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

NCT01158274

Conditions: AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +151 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction

NCT00499811

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +112 more
Locations: City of Hope Medical Center Duarte, California, United States

University of Southern California Los Angeles, California, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

National Institutes of Health Bethesda, Maryland, United States

View Trial Details

Completed

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00769288

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
Locations: Wayne State University Detroit, Michigan, United States

View Trial Details

Completed

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00293345

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +107 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +109 more
Locations: University of Colorado Denver, Colorado, United States

View Trial Details

Completed

17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas

NCT00089271

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blood Protein Disorders, +97 more
Locations: University of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

NCT00003970

Conditions: AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma, +99 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Active, Not Recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details